Our Business
Pharmaceutical Manufacturing and Sales Business
- Manufacture
- Contract
- Sales
KYOSOMIRAI PHARMA CO., LTD.
(Pharmaceutical manufacturing and sales company)
- Address
- 1-4-4, Hiromachi, Shinagawa-ku, Tokyo 140-0005, Japan
- URL
- https://www.kyosomirai-p.co.jp
Manufacturing and selling high-quality pharmaceuticals,
and establishing an integrated contract manufacturing system that supports the entire process from development to production
KYOSOMIRAI PHARMA CO., LTD., which is responsible for the pharmaceutical manufacturing and sales business, produces and sells high-quality generic drugs.
We also offer a comprehensive range of services, including contract manufacturing of ampoule and vial formulations,
development work from formulation design to application support for injectables, and actual production.
Additionally, we conduct contract testing for pharmaceutical quality control and stability testing.
Development and supply infrastructure that underpins the value of pharmaceuticals
-
01
Reliable and stable supply of
high-quality generic drugs -
02
Contract manufacturing of ampoule and vial formulations, and comprehensive development support
-
03
Opening of the Haneda Packaging Center, secondary packaging facility
01
Reliable and stable supply of
high-quality generic drugs
The manufacturing of generic drugs is subject to the same strict Good Manufacturing Practice (GMP) Guideline as brand-name drugs.
KYOSOMIRAI PHARMA conducts a wide range of tests and inspections, from the procurement of raw materials and
supplies through each production process to shipment approval, to ensure a stable and continuous supply of high-quality, high-value-added generic drugs.
Furthermore, leveraging the Group’s network of pharmaceutical wholesaling and dispensing pharmacy businesses, we have established a pharmaceutical supply chain that spans from manufacturing to distribution and dispensing based on accurate market demand forecasts.
Supply chain supporting
the stable supply of generic drugs
02
Contract manufacturing of ampoule and vial formulations,
and comprehensive development support
While the manufacture and sale of injectable formulations, which are prescription pharmaceuticals, serve as one of the pillars of the business,
we also provide contract manufacturing services for ampoule and vial formulations,
as well as contract services for pharmaceutical quality control testing and stability testing.
For injectable formulations, by providing comprehensive contract services covering all processes from development activities,
which range from formulation design to new drug application, to actual production, we can reduce the time and cost associated with technology transfer and validation that would otherwise be required if each process were outsourced separately.
03
Opening of the Haneda Packaging Center,
secondary packaging facility
We have opened the Haneda Packaging Center, a secondary packaging facility, to serve domestic and international biotech ventures and
overseas pharmaceutical companies that do not have infrastructure in Japan.
The center is equipped with facilities for inspection, packaging, and storage, mainly of vial products and similar items,
positioning it to receive contracted operations from manufacturers who lack such facilities.
It is located in the same facility as the Group’s high-function TBC DynaBASE logistics center,
which is also the site of our manufacturer warehouse and wholesale warehouse.
This will make it possible to reduce temperature excursions, vibration, and lead time,
which are issues in the handling of biopharmaceuticals, regenerative medical products, and related items.
